FDA Adverse Event Injury Summary report: N

IMPLANTABLE INFUSION PUMP

MDR report key: 5701132 · Received June 6, 2016

Report

Report Number
3007566237-2016-02204
Event Type
Injury
Date Received
June 6, 2016
Date of Event
January 1, 2016
Report Date
June 6, 2016
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
LKK
PMA / PMN Number
P860004
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

IT WAS NOT POSSIBLE TO MATCH THIS EVENT WITH ANY PREVIOUSLY REPORTED EVENT. INFORMATION REFERENCES THE MAIN COMPONENT OF THE SYSTEM AND OTHER APPLICABLE COMPONENTS ARE: PRODUCT ID: NEU_UNKNOWN_CATH, PRODUCT TYPE: CATHETER .

Description of Event or Problem · 1

STAMPACCHIA, G., MAZZOLENI, S., GERINI, A. EFFECTS OF SEVERE SPASTICITY TREATMENT WITH INTRATHECAL BACLOFEN IN MULTIPLE SCLEROSIS PATIENTS: LONG TERM FOLLOW-UP. NEUROREHABILITATION. 2016. DOI:10.3233/NRE-161329 SUMMARY: INTRATHECAL BACLOFEN IS AVAILABLE TO TREAT SEVERE GENERALIZED SPASTICITY IN MULTIPLE SCLEROSIS (MS) UNRESPONSIVE TO ORAL DRUG DELIVERY. THE AIMS OF THIS STUDY WERE TO INVESTIGATE THE EFFECTS AND THE DRUG DOSAGE OF INTRATHECAL BACLOFEN IN A SELECTED POPULATION OF MS PATIENTS, AFFECTED BY SEVERE SPASTICITY AT LONG TERM FOLLOW-UP. REPORTED EVENTS: COMPLICATIONS DUE TO THE PUMP AND CATHETER IMPLANTATION WERE OBSERVED IN ONLY ONE PATIENT; A CATHETER OBSTRUCTION PREVENTED THE ADEQUATE INTRATHECAL DRUG INFUSION AND THE EFFECT OBSERVED AFTER THE PREOPERATIVE. BACLOFEN BOLUS WAS NOT OBSERVED AFTER THE IMPLANTATION DESPITE THE PROGRESSIVE DOSE INCREASE. A NEW CATHETER AND PUMP REPLACEMENT WAS NECESSARY TO OBTAIN THE EXPECTED EFFECT OF INTRATHECAL BACLOFEN DELIVERY. THE CAUSE OF THIS UNIQUE COMPLICATION WAS A CATHETER MANUFACTURING DEFECT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
355479 IMPLANTABLE INFUSION PUMP PUMP, INFUSION, IMPLANTED, PROGRAMMABLE LKK MEDTRONIC NEUROMODULATION NEU_UNKNOWN_PUMP UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention